TY - STD TI - Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, Suppl 1. 2006;95:S161–92. ID - ref1 ER - TY - JOUR AU - Winter, W. E. AU - Maxwell, G. L. AU - Tian, C. AU - Sundborg, M. J. AU - Rose, G. S. AU - Rose, P. G. PY - 2008 DA - 2008// TI - Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a gynecologic oncology group study JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.1953 DO - 10.1200/JCO.2007.13.1953 ID - Winter2008 ER - TY - JOUR AU - Winter, W. E. AU - Maxwell, G. L. AU - Tian, C. AU - Carlson, J. W. AU - Ozols, R. F. AU - Rose, P. G. PY - 2007 DA - 2007// TI - Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.2517 DO - 10.1200/JCO.2006.10.2517 ID - Winter2007 ER - TY - JOUR AU - Eisenhauer, E. L. AU - Abu-Rustum, N. R. AU - Sonoda, Y. AU - Aghajanian, C. AU - Barakat, R. R. AU - Chi, D. S. PY - 2008 DA - 2008// TI - The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer JO - Gynecol Oncol VL - 108 UR - https://doi.org/10.1016/j.ygyno.2007.10.022 DO - 10.1016/j.ygyno.2007.10.022 ID - Eisenhauer2008 ER - TY - JOUR AU - Chi, D. S. AU - Eisenhauer, E. L. AU - Lang, J. AU - Huh, J. AU - Haddad, L. AU - Abu-Rustum, N. R. PY - 2006 DA - 2006// TI - What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? JO - Gynecol Oncol VL - 103 UR - https://doi.org/10.1016/j.ygyno.2006.03.051 DO - 10.1016/j.ygyno.2006.03.051 ID - Chi2006 ER - TY - JOUR AU - Allensworth, S. K. AU - Langstraat, C. L. AU - Martin, J. R. AU - Lemens, M. A. AU - McGree, M. E. AU - Weaver, A. L. PY - 2013 DA - 2013// TI - Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer JO - Gynecol Oncol VL - 130 UR - https://doi.org/10.1016/j.ygyno.2013.05.038 DO - 10.1016/j.ygyno.2013.05.038 ID - Allensworth2013 ER - TY - JOUR AU - Cohen, J. G. AU - Tran, A. Q. AU - Rimel, B. J. AU - Cass, I. AU - Walsh, C. S. AU - Karlan, B. Y. PY - 2014 DA - 2014// TI - Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival JO - Gynecol Oncol VL - 132 UR - https://doi.org/10.1016/j.ygyno.2014.01.003 DO - 10.1016/j.ygyno.2014.01.003 ID - Cohen2014 ER - TY - JOUR AU - Menczer, J. PY - 2017 DA - 2017// TI - Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies JO - Arch Gynecol Obstet VL - 295 UR - https://doi.org/10.1007/s00404-016-4212-9 DO - 10.1007/s00404-016-4212-9 ID - Menczer2017 ER - TY - JOUR AU - Digklia, A. AU - Voutsadakis, I. A. PY - 2014 DA - 2014// TI - Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer JO - Obstet Gynecol Sci VL - 57 UR - https://doi.org/10.5468/ogs.2014.57.6.457 DO - 10.5468/ogs.2014.57.6.457 ID - Digklia2014 ER - TY - JOUR AU - Chen, Y. AU - Zhang, L. AU - Liu, W. -. X. AU - Liu, X. -. Y. PY - 2015 DA - 2015// TI - Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer JO - Asian Pac J Cancer Prev VL - 16 UR - https://doi.org/10.7314/APJCP.2015.16.3.933 DO - 10.7314/APJCP.2015.16.3.933 ID - Chen2015 ER - TY - JOUR AU - Cozzi, G. D. AU - Samuel, J. M. AU - Fromal, J. T. AU - Keene, S. AU - Crispens, M. A. AU - Khabele, D. PY - 2016 DA - 2016// TI - Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2660-z DO - 10.1186/s12885-016-2660-z ID - Cozzi2016 ER - TY - JOUR AU - Gungor, T. AU - Kanat-Pektas, M. AU - Sucak, A. AU - Mollamahmutoglu, L. PY - 2009 DA - 2009// TI - The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors JO - Arch Gynecol Obstet VL - 279 UR - https://doi.org/10.1007/s00404-008-0673-9 DO - 10.1007/s00404-008-0673-9 ID - Gungor2009 ER - TY - JOUR AU - Lee, M. AU - Kim, S. W. AU - Nam, E. J. AU - Yim, G. W. AU - Kim, S. AU - Kim, Y. T. PY - 2011 DA - 2011// TI - The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer JO - Gynecol Oncol VL - 122 UR - https://doi.org/10.1016/j.ygyno.2011.04.012 DO - 10.1016/j.ygyno.2011.04.012 ID - Lee2011 ER - TY - JOUR AU - Li, A. J. AU - Madden, A. C. AU - Cass, I. AU - Leuchter, R. S. AU - Lagasse, L. D. AU - Karlan, B. Y. PY - 2004 DA - 2004// TI - The prognostic significance of thrombocytosis in epithelial ovarian carcinoma JO - Gynecol Oncol VL - 92 UR - https://doi.org/10.1016/j.ygyno.2003.09.002 DO - 10.1016/j.ygyno.2003.09.002 ID - Li2004 ER - TY - JOUR AU - Qiu, J. AU - Yu, Y. AU - Fu, Y. AU - Ye, F. AU - Xie, X. AU - Lu, W. PY - 2012 DA - 2012// TI - Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer JO - J Obstet Gynaecol Res VL - 38 UR - https://doi.org/10.1111/j.1447-0756.2011.01780.x DO - 10.1111/j.1447-0756.2011.01780.x ID - Qiu2012 ER - TY - JOUR AU - Buergy, D. AU - Wenz, F. AU - Groden, C. AU - Brockmann, M. A. PY - 2012 DA - 2012// TI - Tumor-platelet interaction in solid tumors JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.27441 DO - 10.1002/ijc.27441 ID - Buergy2012 ER - TY - JOUR AU - Dijkgraaf, E. AU - Santegoets, S. AU - Reyners, A. AU - Goedemans, R. AU - Wouters, M. AU - Kenter, G. PY - 2015 DA - 2015// TI - A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv309 DO - 10.1093/annonc/mdv309 ID - Dijkgraaf2015 ER - TY - JOUR AU - Angevin, E. AU - Tabernero, J. AU - Elez, E. AU - Cohen, S. J. AU - Bahleda, R. AU - Laethem, J. -. L. PY - 2014 DA - 2014// TI - A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2200 DO - 10.1158/1078-0432.CCR-13-2200 ID - Angevin2014 ER - TY - JOUR AU - Satoh, T. AU - Oki, A. AU - Uno, K. AU - Sakurai, M. AU - Ochi, H. AU - Okada, S. PY - 2007 DA - 2007// TI - High incidence of silent venous thromboembolism before treatment in ovarian cancer JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6603989 DO - 10.1038/sj.bjc.6603989 ID - Satoh2007 ER - TY - JOUR AU - Feng, Z. AU - Wen, H. AU - Bi, R. AU - Duan, Y. AU - Yang, W. AU - Wu, X. PY - 2016 DA - 2016// TI - Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2070-2 DO - 10.1186/s12885-016-2070-2 ID - Feng2016 ER - TY - JOUR AU - Colombo, N. AU - Gore, M. PY - 2007 DA - 2007// TI - Treatment of recurrent ovarian cancer relapsing 6–12 months post platinum-based chemotherapy JO - Crit Rev Oncol Hematol VL - 64 UR - https://doi.org/10.1016/j.critrevonc.2007.04.004 DO - 10.1016/j.critrevonc.2007.04.004 ID - Colombo2007 ER - TY - JOUR AU - Markman, M. AU - Rothman, R. AU - Hakes, T. AU - Reichman, B. AU - Hoskins, W. AU - Rubin, S. PY - 1991 DA - 1991// TI - Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin JO - J Clin Oncol VL - 9 UR - https://doi.org/10.1200/JCO.1991.9.3.389 DO - 10.1200/JCO.1991.9.3.389 ID - Markman1991 ER - TY - JOUR AU - Harries, M. AU - Gore, M. PY - 2002 DA - 2002// TI - Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00847-1 DO - 10.1016/S1470-2045(02)00847-1 ID - Harries2002 ER - TY - STD TI - Huong PT, Nguyen LT, Nguyen XB, Lee SK, Bach DH. The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells. Cancers (Basel). 2019;11(2). ID - ref24 ER - TY - JOUR AU - Lagana, A. S. AU - Sofo, V. AU - Vitale, S. G. AU - Triolo, O. PY - 2016 DA - 2016// TI - Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? JO - Gynecol Oncol Rep VL - 18 UR - https://doi.org/10.1016/j.gore.2016.09.004 DO - 10.1016/j.gore.2016.09.004 ID - Lagana2016 ER - TY - JOUR AU - Chiu, W. T. AU - Huang, Y. F. AU - Tsai, H. Y. AU - Chen, C. C. AU - Chang, C. H. AU - Huang, S. C. PY - 2015 DA - 2015// TI - FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.2957 DO - 10.18632/oncotarget.2957 ID - Chiu2015 ER - TY - JOUR AU - Radziwon-Balicka, A. AU - Medina, C. AU - O'Driscoll, L. AU - Treumann, A. AU - Bazou, D. AU - Inkielewicz-Stepniak, I. PY - 2012 DA - 2012// TI - Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance JO - Br J Pharmacol VL - 167 UR - https://doi.org/10.1111/j.1476-5381.2012.01991.x DO - 10.1111/j.1476-5381.2012.01991.x ID - Radziwon-Balicka2012 ER - TY - JOUR AU - Bottsford-Miller, J. AU - Choi, H. J. AU - Dalton, H. J. AU - Stone, R. L. AU - Cho, M. S. AU - Haemmerle, M. PY - 2015 DA - 2015// TI - Differential platelet levels affect response to taxane-based therapy in ovarian cancer JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-0870 DO - 10.1158/1078-0432.CCR-14-0870 ID - Bottsford-Miller2015 ER - TY - JOUR AU - Stone, R. L. AU - Nick, A. M. AU - McNeish, I. A. AU - Balkwill, F. AU - Han, H. D. AU - Bottsford-Miller, J. PY - 2012 DA - 2012// TI - Paraneoplastic thrombocytosis in ovarian cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1110352 DO - 10.1056/NEJMoa1110352 ID - Stone2012 ER - TY - JOUR AU - Coward, J. AU - Kulbe, H. AU - Chakravarty, P. AU - Leader, D. AU - Vassileva, V. AU - Leinster, D. A. PY - 2011 DA - 2011// TI - Interleukin-6 as a therapeutic target in human ovarian cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0945 DO - 10.1158/1078-0432.CCR-11-0945 ID - Coward2011 ER - TY - JOUR AU - Dijkgraaf, E. M. AU - Santegoets, S. J. AU - Reyners, A. K. AU - Goedemans, R. AU - Wouters, M. C. AU - Kenter, G. G. PY - 2015 DA - 2015// TI - A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv309 DO - 10.1093/annonc/mdv309 ID - Dijkgraaf2015 ER -